ClinicalTrials.govpublic full text
Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
raynaud's disease, raynaud's phenomenon, raynaud's disease secondary to scleroderma, raynaud's phenomenon secondary to autoimmune disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1045048
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.